XML 118 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
Significant transactions (Details)
$ / shares in Units, € in Millions
1 Months Ended 12 Months Ended
Dec. 06, 2022
USD ($)
Nov. 21, 2022
USD ($)
$ / shares
Jul. 08, 2022
USD ($)
May 31, 2022
USD ($)
May 31, 2022
EUR (€)
Jan. 07, 2022
USD ($)
Jun. 08, 2021
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
May 31, 2022
EUR (€)
May 30, 2022
USD ($)
Disclosure of detailed information about business combination [line items]                          
Consideration paid                 $ 0 $ 666,000,000 $ 0    
Goodwill               $ 8,926,000,000 8,926,000,000 8,926,000,000      
Borrowings               4,739,000,000 4,739,000,000 4,648,000,000      
Repayments of non-current borrowings                 0 1,176,000,000 0    
Purchase of intangible assets               3,000,000 193,000,000 $ 109,000,000 $ 480,000,000    
Aerie Pharmaceuticals, Inc.                          
Disclosure of detailed information about business combination [line items]                          
Percentage of voting equity interests acquired (as a percent)   100.00%                      
Price paid (in dollars per share) | $ / shares   $ 15.25                      
Consideration transferred   $ 744,000,000                      
Consideration paid   666,000,000                      
Borrowings recognised as of acquisition date   316,200,000                      
Goodwill   65,000,000                      
Business combinations                          
Disclosure of detailed information about business combination [line items]                          
Consideration transferred   744,000,000           744,000,000 744,000,000        
Borrowings recognised as of acquisition date   316,000,000           316,000,000 316,000,000        
Goodwill   65,000,000           $ 21,000,000 $ 21,000,000        
Eysuvis and Inveltys                          
Disclosure of detailed information about business combination [line items]                          
Upfront payment     $ 60,000,000                    
Purchase consideration     79,000,000                    
Intangible assets     71,000,000                    
Inventory, net of liabilities     $ 14,000,000                    
Ivantis, Inc.                          
Disclosure of detailed information about business combination [line items]                          
Percentage of voting equity interests acquired (as a percent)           100.00%              
Upfront payment           $ 479,000,000              
Simbrinza                          
Disclosure of detailed information about business combination [line items]                          
Purchase of intangible assets             $ 355,000,000            
Series 2032 Notes                          
Disclosure of detailed information about business combination [line items]                          
Borrowings $ 700,000,000                        
Borrowings, interest rate (as a percent) 5.375%             5.375% 5.375%        
Series 2052 Notes                          
Disclosure of detailed information about business combination [line items]                          
Borrowings $ 600,000,000                        
Borrowings, interest rate (as a percent) 5.75%             5.75% 5.75%        
Facility B Term Loan                          
Disclosure of detailed information about business combination [line items]                          
Borrowings                         $ 800,000,000
Repayments of non-current borrowings $ 640,000,000     $ 160,000,000                  
Bridge Loan Facility                          
Disclosure of detailed information about business combination [line items]                          
Borrowings   $ 775,000,000                      
Repayments of non-current borrowings $ 775,000,000                        
Series 2028 Notes                          
Disclosure of detailed information about business combination [line items]                          
Borrowings       $ 537,000,000       $ 553,000,000 $ 553,000,000     € 500  
Borrowings, interest rate (as a percent)       2.375%       2.375% 2.375%     2.375%  
Facility C Term Loan                          
Disclosure of detailed information about business combination [line items]                          
Repayments of non-current borrowings       $ 376,000,000 € 350